Lanfranco Pellesi

About Lanfranco Pellesi

Lanfranco Pellesi, With an exceptional h-index of 15 and a recent h-index of 15 (since 2020), a distinguished researcher at Københavns Universitet, specializes in the field of Clinical Pharmacology, Neurology, Headaches.

His recent articles reflect a diverse array of research interests and contributions to the field:

Triptan treatment is associated with a higher number of red wine‐induced migraine episodes: An exploratory questionnaire‐based survey

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?

The human NTG model of migraine in drug discovery and development

Plasma levels of VIP are not elevated during PACAP-and VIP-induced cluster headache attacks: an exploratory study

Combining two CGRP inhibitors to treat migraine

PACAP38-and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation

Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial

Lanfranco Pellesi Information

University

Position

Danish Headache Center Department of Neurology Rigshospitalet Glostrup

Citations(all)

758

Citations(since 2020)

661

Cited By

318

hIndex(all)

15

hIndex(since 2020)

15

i10Index(all)

18

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Lanfranco Pellesi Skills & Research Interests

Clinical Pharmacology

Neurology

Headaches

Top articles of Lanfranco Pellesi

Triptan treatment is associated with a higher number of red wine‐induced migraine episodes: An exploratory questionnaire‐based survey

Pain Practice

2024/3/7

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

2024/2/12

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Paolo Martelletti
Paolo Martelletti

H-Index: 39

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?

Frontiers in Pain Research

2023/10/27

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

The human NTG model of migraine in drug discovery and development

2023/10/3

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Plasma levels of VIP are not elevated during PACAP-and VIP-induced cluster headache attacks: an exploratory study

Frontiers in Neurology

2023/4/18

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Combining two CGRP inhibitors to treat migraine

2022/9/2

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

PACAP38-and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation

Cephalalgia

2022/7

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial

Pain

2022/5/13

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Håkan Ashina
Håkan Ashina

H-Index: 10

Plasma levels of CGRP during a 2-h infusion of VIP in healthy volunteers and patients with migraine: an exploratory study

Frontiers in Neurology

2022/4/1

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Clinical evidence of cannabinoids in migraine: a narrative review

2022/3/8

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Vasodilating, parasympathetic and migraine inducingproperties of a long-lasting infusion of VIP

2022

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Safety and risk of medication overuse headache in lasmiditan and second-generation gepants: a rapid review

2021/11/23

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Greater Occipital Nerve Block with Local Anesthetics and Corticosteroids in Treatment-Resistant Chronic Migraine

Headache Medicine

2021/11/16

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Effect of vasoactive intestinal polypeptide on development of migraine headaches: a randomized clinical trial

JAMA network open

2021/8/2

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine

2021/4/3

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Morten Andersen
Morten Andersen

H-Index: 20

Nummular headache: A gender-oriented perspective on a case series from the RegistRare Network

Neurological Sciences

2020/3

Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers

Cephalalgia

2020/10

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study

Cephalalgia

2020/9

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Elisa Bellei
Elisa Bellei

H-Index: 11

Reducing episodic cluster headaches: focus on galcanezumab

2020/7/2

Lanfranco Pellesi
Lanfranco Pellesi

H-Index: 11

Dual therapy with anti‐CGRP monoclonal antibodies and botulinum toxin for migraine prevention: is there a rationale?

2020/6

See List of Professors in Lanfranco Pellesi University(Københavns Universitet)

Co-Authors

academic-engine